MwanzoYPH • FRA
add
Astellas Pharma Inc
Bei iliyotangulia
€ 8.70
Bei za siku
€ 8.69 - € 8.81
Bei za mwaka
€ 8.53 - € 15.61
Thamani ya kampuni katika soko
2.73T JPY
Wastani wa hisa zilizouzwa
145.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TYO
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (JPY) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 421.93B | 4.91% |
Matumizi ya uendeshaji wa biashara | 327.17B | 23.00% |
Mapato halisi | 14.51B | -70.02% |
Kiwango cha faida halisi | 3.44 | -71.43% |
Mapato kwa kila hisa | — | — |
EBITDA | 65.85B | -22.30% |
Asilimia ya kodi ya mapato | 16.17% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (JPY) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 285.44B | -30.94% |
Jumla ya mali | 3.37T | 34.00% |
Jumla ya dhima | 1.87T | 97.71% |
Jumla ya hisa | 1.50T | — |
hisa zilizosalia | 1.79B | — |
Uwiano wa bei na thamani | 0.01 | — |
Faida inayotokana na mali | 1.36% | — |
Faida inayotokana mtaji | 1.92% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (JPY) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 14.51B | -70.02% |
Pesa kutokana na shughuli | 51.41B | -28.90% |
Pesa kutokana na uwekezaji | -40.31B | -48.64% |
Pesa kutokana na ufadhili | -87.02B | -798.18% |
Mabadiliko halisi ya pesa taslimu | -80.02B | -485.74% |
Mtiririko huru wa pesa | 31.33B | 428.72% |
Kuhusu
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. On February 5, 2020, the company announced management changes effective from April 1, 2020.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1 Apr 2005
Makao Makuu
Tovuti
Wafanyakazi
14,484
